On June 29, 2021, Health Canada issued a Health Product Risk Communication regarding the AstraZeneca/COVISHIELD COVID-19 vaccine: https://healthycanadians.gc.ca/recall-alert-rappel- avis/hc-sc/2021/75389a-eng.php Health Canada has updated the product monograph for the AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side effect following vaccination. Patients with a history of capillary leak syndrome should not...
Tag: news
Post
Pregnancy added to Highest Risk conditions for COVID-19 vaccine
In response to emerging data on the increased risk of severe illness for pregnant individuals, Ontario’s Vaccine Clinical Advisory Group (VCAG) has recommended the inclusion of pregnant individuals in the Highest Risk category of health conditions. As part of this group, pregnant individuals and one primary caregiver are now eligible to receive their COVID-19 vaccines...
Post
Health Canada provides update on the AstraZeneca and COVISHIELD COVID-19 vaccines
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75389a-eng.php HMC
Post
COVID-19 Vaccines
Dear community members and families, In the last few weeks, we have seen significant movement in our understanding of the COVID-19 vaccines. As of today, here is what we know: The vaccines are safe The vaccines approved for use in Canada work by sending a message to our body’s immune system to stimulate our natural immune response....
Post
Pharmascience Inc. recalls certain lots of over-the-counter ranitidine
Pharmascience Inc. is recalling 13 additional lots of its store-brand over-the-counter ranitidine products (75 mg strength tablet) after tests found NDMA, a nitrosamine impurity, above accepted levels. HMC
Post
Health Canada assessing NDMA in ranitidine
Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. Health Canada is closely assessing the issue in collaboration with other regulators internationally, including the U.S. Food and Drug Administration and the European Medicines Agency. The Department will take action as needed, and will keep...